Explain How The Head Of The CDC Left To Become The Head Of The Vaccine Division At Merck

Explain How The Head Of The CDC Left To Become The Head Of The Vaccine Division At Merck

Explain How The Head Of The CDC Left To Become The Head Of The Vaccine Division At Merck

131K subscribers
The CDC’s bloated vaccine schedule has doubled since 1988 after the federal government gave pharmaceutical companies immunity from lawsuits. Autism and other childhood disorders like asthma, ADHD, juvenile diabetes, and digestive ailments have skyrocketed. And parents are understandably nervous, desperate for objective guidance that takes those concerns seriously. Mark Blaxill is co-founder and Executive Director of XLP Capital, a firm founded in 2015 and focused on technology strategy development, new technology business incubation, and technology-based investments. He often writes on autism, science and public policy issues for Age of Autism and has published a number of articles, letters and commentaries on autism in journals such as Public Health Reports, the International Journal of Toxicology, the Journal of Autism and Developmental Disorders, Frontiers in Pediatrics, Neurotoxicology and Medical Hypotheses. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Tru… https://www.instagram.com/therealtrut… https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO’s. Fighting to stop climate change and extinction.

Don’t stop now — the rest is one click away

One free account opens this and the whole library. Instant access. No card. No catch.

Come Join Here

Selalu – For Light Minded Friends

Selalu – For Light Minded Friends

Amazing Books

Amazing Books

1 400 Interviews

1 400 Fascinating Interviews

Unique Coaching

Unique Coaching

The World’s Biggest Research Vault

World's Biggest Research Vault

Ole’s Creative Daughter

Ole's Creative Daughter

Wake Up – Straight to No1 !

Wake Up – Straight to No1 !

Join Ole’s Supporters

Join Ole's Supporters

Support Ole’s Research

Support Ole's Groundbreaking Research